No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

ROM InWest Invests €1.5 million into AI and Computer Vision Company Kepler Vision Technologies

Summation

  • This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.
  • A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow.
  • Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work.

ROM InWest Invests

Kepler Vision Technologies, a software developer in the healthcare sector, has received an investment of €1.5 million from Dutch investment company ROM InWest. With the investment, the health-technology company will scale up the production of their Kepler Night Nurse. This smart sensor technology, applicable in elderly care among others, helps reduce the workload for healthcare professionals while simultaneously improving the quality of care.

Kepler Vision’s Night Nurse

Kepler Vision’s Night Nurse solution is a computer vision-based body language detection system. By combining AI and computer vision, Kepler Night Nurse is able to detect falls, patient discomfort and abnormal behaviour, notifying care staff so that they can respond immediately. The company has also recently added a new lying position detection feature that identifies the potential of pressure ulcers. This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.

International Distribution

The Night Nurse product has already been distributed internationally across 8 European countries through 26 different partners in care homes and hospitals. With the investment from ROM InWest, the company will look to widen its reach with plans of entering the UK and US market already in motion.

Harro Stokman, CEO of Kepler Vision Technologies says:

“The healthcare sector has been facing urgent staff shortages for years. This problem is only getting worse due to an aging population. A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow. Elderly care therefore needs more support than ever. Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work. My goal is for our software to be accessible across the world, and with great support like this, we get closer to achieving this”.

Janet Nieboer, CEO of ROM InWest comments:

“We are proud to contribute to Kepler’s healthcare solution. The Kepler Night Nurse offers a smart and more reliable alternative to existing home automation systems. It contributes to good patient care and makes the work of healthcare professionals more efficient. Smart healthcare solutions like these are essential to maintain the quality and affordability of our healthcare.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

E Tech Group Secures New Investment from Graham Partners, Sets Stage for Continued Growth and Innovation

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.

Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025

Nawal Ouzren, Sensorion’s Chief Executive Officer, said: “We are thrilled to announce another successful capital raise, securing an additional EUR 15 million to accommodate interest expressed by certain existing investors. This builds on the earlier EUR 50 million financing announced in February 2024, adding up to a total of EUR 100 million raised in less than 9 months. With this new financing, we are well-positioned to accelerate our gene therapy programs, including the progression of SENS-501 through its Phase 1/2 clinical study, Audiogene, and the advancement of our second program, GJB2-GT, towards Clinical Trial Applications submission in H1 2025. The capital increase enables the Company to finance its activities until the end of 2025. We remain deeply thankful for the ongoing support of our shareholders and partners as we strive to make a meaningful difference in the lives of those affected by hearing loss disorders.”

Kryptos Biotechnologies Secures $10 Mil in Series A Funding | Funds to Be Used for Clinical Studies and FDA Approval of their Molecular Diagnostics System

Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing.

By using this website you agree to accept Medical Device News Magazine Privacy Policy